Responses to crizotinib and chemotherapy in patients with lung adenocarcinoma harboring a concomitant EGFR mutation and ALK gene rearrangement: A case report and review of the literature.
Molecular and clinical oncology Aug, 2017 | Pubmed ID: 28781781